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HtrA1, Ddr-2, and Mmp-13 are reliable biomarkers for osteoarthritis (OA), yet the exact
mechanism for the upregulation of HtrA-1 is unknown. Some have shown that chondrocyte
hypertrophy is associated with early indicators of inflammation including TGF-β and
the Receptor for Advanced Glycation End-products (RAGE). To examine the correlation
of inflammation with the expression of biomarkers in OA, we performed right knee
destabilization surgery on 4-week-old-wild type and RAGE knock-out (KO) mice. We
assayed for HtrA-1, TGF-β1, Mmp-13, and Ddr-2 in articular cartilage at 3, 7, 14, and 28
days post-surgery by immunohistochemistry on left and right knee joints. RAGE KO and
wild type mice both showed staining for key OA biomarkers. However, RAGE KO mice
were significantly protected against OA compared to controls. We observed a difference
in the total number of chondrocytes and percentage of chondrocytes staining positive for
OA biomarkers between RAGE KO and control mice. The percentage of cells staining for
OA biomarkers correlated with severity of cartilage degradation. Our results indicate that
the absence of RAGE did protect against the development of advanced OA. We conclude
that HtrA-1 plays a role in lowering TGF-β1 expression in the process of making articular
cartilage vulnerable to damage associated with OA progression.
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INTRODUCTION
Osteoarthritis (OA) is one of the most common chronic diseases
in the United States, and given the aging and obesity of
the population, its prevalence is increasing. OA is character-
ized by joint pain, joint effusion, loss of mobility, and defor-
mity that can progress to functional joint failure. More than
80% of people older than 65 years are symptomatic for OA
(Chien et al., 2009).
Although the multifactorial nature of OA is well-recognized,
little is known about the underlying molecular mechanisms lead-
ing to this disorder or the modalities that sustain them. OA
is associated with several different inherited chondrodysplasia
syndromes such as Stickler syndrome, caused bymutations in col-
lagens or other cartilage specific genes. However, in most adults
OA is associated with risk factors such as aging, obesity, repetitive
stress, joint misalignment, acute injury, or genetic predisposition.
Whether OA is triggered by mechanical stress or by a genetic
abnormality, the end result is the same—a painful and progres-
sive degeneration of the articular surface with thinning, fissuring,
and ultimately loss of the functional, protective articular surface
of the joint.
An important focus in the field of OA research at present is
determining whether the different forms of OA that develop as
a result of genetic predisposition, chronic joint stress, or acute
injury all follow the same molecular pathway. We and others have
shown that HtrA-1, Ddr-2, and Mmp-13, with HtrA-1 appearing
first temporally, are components of a common molecular path-
way (Murwantoko et al., 2004; Polur et al., 2010; Holt et al.,
2012). OA progresses as HtrA-1 and Mmp-13, matrix-degrading
enzymes, are synthesized and secreted from chondrocytes leading
to the weakening of the articular cartilage. Early in the initia-
tion of OA, an initial attempt to repair the region coincides with
increased synthesis of cartilage matrix and increased proliferation
of chondrocytes to form clones or clusters. Despite the attempt
at early repair, the limited matrix synthesis is overwhelmed by
the increased activity ofmatrix-degrading enzymes. The damaged
cartilage surface, characteristic of late OA, is irreparable since
adult articular chondrocytes cannot regenerate normal cartilage
matrix. Importantly, this molecular metabolic pathway has also
been previously demonstrated in surgically induced OA (Xu et al.,
2010). Since HtrA-1, Ddr-2, and Mmp-13 are reliable biomark-
ers of OA, with HtrA-1 leading to the expression/upregulation of
Ddr-2 and Mmp-13, a key to abrogating OAmight lie in blocking
the initiation of HtrA-1.
Formerly, OA was thought to be a disease of “wear and tear,”
that is, a disorder in which mechanical forces physically degrade
the articular cartilage surface. However, OA is increasingly viewed
as a metabolically active, dynamic process involving inflamma-
tory mediators, for review see Berenbaum (2013). In this scenario
HtrA-1 upregulation may be associated with a biomarker(s) of an
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inflammatory pathway(s). It is, therefore, possible that blocking
or inhibiting early stages of inflammation will attenuate OA.
The Receptor for Advanced Glycation End-products (RAGEs)
are cell-surface receptors of the immunoglobulin superfam-
ily expressed in diverse cell types. Studies have distinguished
RAGE as a pattern recognition receptor that binds endogenous
S100/calgranulins, amyloid-β-peptide, and HMGB-1 (or ampho-
terin), to influence gene expression via activated signal transduc-
tion pathways. Specifically, a host of pro-inflammatory responses
such as those coordinated by MAP kinases, NF-κB, reactive oxy-
gen species, and other pro-inflammatory mediators such as TNF,
IL-1, TGF-β (Fukami et al., 2004) result from RAGE-ligand inter-
actions. Engagement of RAGE by its ligands results in prolonged
inflammation. Alarmins have been previously shown to be asso-
ciated with OA, working through RAGE (Nakashima et al., 2012;
Schelbergen et al., 2012). It is of interest to note that TGF-β1 has
been shown to be involved both in chondrocyte regulation and
the early pathogenesis of cartilage diseases (Grimaud et al., 2002).
In the present study, we examined the role of inflammation in
OA by performing knee destabilization surgery on wild type and
RAGE knock-out (KO) mice according to established procedures
(Xu et al., 2010). We chose to use young mice to exclude any effect
of aging on the development of OA. We report that OA was abro-
gated in RAGE KO mouse knee joints compared to destabilized
joints from wild type mice. Furthermore, the data demonstrate
an important relationship between RAGE, TGF-β1, and HtrA-1
in the progression of OA.
MATERIALS AND METHODS
MICE AND JOINT DESTABILIZATION PROCEDURE
RAGE KO mice that lack membrane and soluble RAGE were
generated on a C57BL/6 background (Wendt et al., 2003). The
RAGE KO have previously been shown to lack any RAGE expres-
sion (Wendt et al., 2003). Wild type/control mice were the same
B57BL/6 background (The Jackson Laboratory, Bar Harbor, ME,
USA; Strain Name: C57BL/6; Stock number 000664). The mice
were randomized for sex and a destabilization of the medial
meniscus (DMM) procedure was performed with 28-day-old-
RAGE KO (n = 7) and wild type (n = 16) mice. Mice were anes-
thetized using an intraperitoneal injection of 0.5–0.7 cc Avertin
IP [0.5ml Avertin solution (15.5ml tert-amyl alcohol to 25 g
Avertin) in 39.5ml normal saline solution] and the skin sur-
rounding the right knee joint was prepped by clipping the fur
and washing with an iodine surgical scrub followed by 70% alco-
hol. The remainder of the procedure was performed under aWild
Heerbrugg 355110 (Wild Heerbrugg AG, Switzerland) surgical
microscope using sterile technique. The medial meniscotibial lig-
ament was exposed by blunt dissection and the joint area was
visualized. The meniscotibial ligament was subsequently tran-
sected using a number 11 scalpel to allow the displacement of
the medial meniscus. Displacement of the meniscus was con-
firmed visually. The joint capsule and skin were both closed
using 7-0 absorbable Vicryl suture (Ethicon, Inc., Somerville,
NJ, USA). A sham procedure was also performed as a control
on wild type (n = 5 for 28-day group, n = 3 for all other time
points) and RAGE KO mice (n = 5) in which the meniscotibial
ligament was exposed but not transected. These procedures were
conducted under a protocol 10-0901 approved by the Brigham
Young University IACUC.
TISSUE PROCESSING
Wild type mice at 3, 7, 14, and 28 days post-surgery (n = 3, 3, 3,
and 7, respectively) and RAGE KO mice at 28 days post-surgery
(n = 7) were euthanized by isoflurane USP (Abbott Laboratories,
North Chicago, IL, USA), and right knee and temporomandibu-
lar (TM) joints were excised and fixed in 4% paraformaldehyde
overnight. Each sample was then washed with H2O over a period
of 6 h with the H2O being exchanged every 30min. The tissues
were decalcified in a formic acid solution that was changed every
2–3 days for a period of 2–3 weeks. Decalcification of each sam-
ple was confirmed through an ammonium oxalate reaction, and
tissues were embedded in paraffin wax using an automated tissue
processor (ThermoFisher Scientific, MA, USA). Paraffin blocks
were prepared with the knee joint bent at a 120◦ angle, with the
anterior tibial surface flush with the cutting surface. TM joints
were embedded in paraffin wax with the joint flush with the
cutting surface to achieve a frontal cut (Bomsta et al., 2006).
Right knee and TM joint blocks were sectioned at 6μm
through the entire joint from the anterior surface to the pos-
terior using a Microm HM 325 microtome (Thermo Scientific,
Kalamazoo, MI, USA). Four to five sections were placed per glass
microscope slide, yielding ∼35–50 slides or ∼160–225 sections
per joint, depending on the animal.
HISTOLOGICAL ANALYSIS
Histopathology was documented by Safranin O and Fast Green
staining of every sixth slide of 3, 7, 14, and 28 days post-
surgery knee samples. Using a light microscope equipped with an
Olympus digital camera (Olympus America Inc., Center Valley,
PA, USA), photographs of each knee joint were taken at 200 and
400× magnifications.
The articular cartilage in two representative sections from each
stained slide was analyzed using a modified Mankin score to
quantify the pathological state of each joint, with a score of 0 rep-
resenting unaltered articular cartilage and 14 representing severe
OA. Overall Mankin scoring was based on a subset of scores
including cartilage erosion score (0–6), chondrocyte periphery
staining (0–2), spatial arrangement of chondrocytes (0–3), and
background staining intensity (0–3) (Mankin et al., 1971; Xu
et al., 2003; Bomsta et al., 2006). Statistical significance of the
combined Mankin scores for the 28 days RAGE KO and wild type
surgery groups using a Two-Way ANOVA test conducted by the
Department of Statistics at Brigham Young University.
IMMUNOHISTOCHEMICAL ANALYSIS
Immunohistochemistry was performed on sections of mouse
knee joints from wild type (3, 7, 14, and 28 days post-surgery)
and RAGE KO mice (28 days post-surgery). Separate slides
were stained with antibodies against HtrA-1, TGF-β1, Ddr-2,
and Mmp-13. Each slide was deparaffinized and then blocked
for 1 h in PBS supplemented with 5% bovine serum albumin
(Sigma-Aldrich, St Louis, MO, USA; B2518) and 0.05% Na
Azide (Sigma-Aldrich, St Louis, MO, USA; S2002). Primary anti-
bodies against HtrA-1 (ab38611) were purchased from Abcam
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(Cambridge, MA, USA), against TGF-β1 (ab92486) from Abcam
(Cambridge, MA, USA), against Ddr-2 (SC-8989) from Santa
Cruz Biotechnology (Santa Cruz, CA, USA), and against Mmp-13
(AB8120) from Chemicon (Temecula, CA, USA). All antibod-
ies were diluted 1:200, applied to specimens, and incubated
overnight at 4◦C. On the second day, samples were rinsed
with PBS and then incubated with an avidin/biotin ABC mix
(Vectastain elite ABC Kit, Vector Laboratories, Inc., Burlingame,
CA, USA). Slides were rinsed a second time with PBS and incu-
bated with biotinylated secondary antibody. After a third PBS
rinse, a color reaction was initiated to achieve a red/brown stain
using a peroxidase substrate (VECTOR NovaRED substrate kit,
Vector Laboratories, Burlingame, CA, USA). A cover slip was
applied prior to photographing. Negative controls were prepared
by staining without the addition of primary antibody. Differences
in staining intensity weremeasured qualitatively with comparison
to wild type control. The qualitative results of the immunohis-
tochemical staining for the RAGE KO and wild type samples
were analyzed statistically using Chi-Squared tests to evaluate
differences between the two samples in staining patterns for
key OA biomarkers. Similar statistical tests were used to also
evaluate the relationship between the presence of TGF-β1 and
HtrA-1 in RAGE KO and wild type samples. The relationship
between immunohistochemical staining and severity of carti-
lage degradation was also evaluated using a Chi-Squared test.
Staining was analyzed quantitatively by calculating the percent-
age of cells staining positive for the respective biomarkers and
the total number of chondrocytes in a defined 200 × 900 pixel
area of articular cartilage immediately distal to the tibial plateau.
All quantitative analysis was performed using ImageJ (National
Institutes of Health, Bethesda, MD, USA). Cell counting was done
by two independent investigators who were blinded both to the
strain of mouse (RAGE KO vs. wild type) and experimental group
(sham vs. surgery). The quantitative results were subsequently
analyzed statistically using an ANOVA test to detect differences in
the mean percentages of positive staining for key OA biomarkers
and mean chondrocyte counts between the RAGE KO and wild
type samples.
RESULTS
RAGE KO MICE ARE PROTECTED AGAINST OA
Both RAGE KO and wild type mice were visualized and his-
tologically analyzed (see Figure 1). While both RAGE KO and
wild type mice demonstrated cartilage degradation following
DMM surgery, tissue loss was markedly accelerated in the wild
type mice. The cartilage degradation was indicated histologically
by the early increase in proteoglycans, clustering of chondro-
cytes, and superficial fibrillation. In the RAGE KO mice, these
indicators of OA were significantly attenuated. Wild type mice
from the 3, 7, and 14 day groups demonstrated only early
signs of cartilage degradation but a marked onset of OA was
observed between the 14 and 28 days post-surgery. We conse-
quently used day 28 as the time point to assess the effects of the
surgery on OA.
To quantitatively evaluate the effect of RAGE on OA patho-
genesis, the modified Mankin scores of the RAGE KO (n = 7)
and wild type (n = 7) surgery and SHAM control mice (n = 3
for RAGE KO and wild type each) were evaluated 28 days
post-surgery. Statistically significant differences were noted
between the mean scores of the surgical and SHAM control
groups (p < 0.01). More importantly, a statistically significant
difference was also noted between the mean modified Mankin
scores of RAGE KO (mean = 2.96) and wild type (mean = 4.89)
mice at 28 days post-surgery (p < 0.05, see Figure 1). These
FIGURE 1 | Articular cartilage degradation from both wild type and
RAGE KO samples was objectively evaluated using a modified
Mankin score by two blind scorers. Tissue samples were collected
from Wild Type (A) and RAGE KO (B) at 28 days post-surgery and
prepared with Safarnin O/Fast Green histological stains prior to Mankin
scoring. Means of RAGE KO (n = 7) and wild type (n = 7) modified
Mankin scores were compared to detect differences in cartilage
degradation, and consequently, differences in OA. The mean of the wild
type sample (modified Mankin Score = 4.89) was significantly higher
than that of the RAGE KO sample (modified Mankin Score = 2.96) as
determined by an ANOVA statistical test (∗p < 0.05). The scale bar, valid
for every image, is 50μm.
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results demonstrate that the absence of RAGE attenuates the
progression of OA.
RAGE KO AND WILD TYPE MICE BOTH SHOW SIMILAR STAINING FOR
KEY BIOMARKERS
Immunohistochemical analysis of the RAGE KO and wild type
surgery groups 28 days post-surgery showed a positive staining for
HtrA-1, Ddr-2, andMmp-13 (See Figure 2). Wild type mice from
the 3, 7, and 14 day groups demonstrated occasional, inconsistent
staining for HtrA-1, Ddr-2, and Mmp-13. More tissue samples
from the wild type sample stained positive for TGF-β1 than
the RAGE KO sample, however no statistically significant was
observed. Furthermore, statistical analysis revealed that there was
no difference in the expression of HtrA-1, Ddr-2, and Mmp-13
when comparing the RAGE KO and wild type surgery groups
(p = 0.30–0.65).
CORRELATION BETWEEN PRESENCE OF TGF-β1 AND HtrA-1
While our statistical analysis did not show any significant dif-
ference in the presence of TGF-β1 between RAGE KO and wild
type mice (p < 0.35), we did observe a significant relationship
between the presence of HtrA-1 and TGF-β1. We observed a
pattern throughout the RAGE KO and wild type mice at 28
days post-surgery (see Table 1) such that when a tissue specimen
stained positive for HtrA-1, it consistently stained negative for
TGF-β1. Conversely, if the specimen stained negative for HtrA-1,
it consistently stained positive for TGF-β1 (p < 0.01).
DIFFERENCES IN TOTAL NUMBER OF CHONDROCYTES AND
PERCENTAGE OF CHONDROCYTES STAINING POSITIVE FOR
OA BIOMARKERS
A quantitative analysis of the immunohistochemical staining elu-
cidated key differences in the percentage of chondrocytes staining
positive for HtrA-1 and Mmp-13 in RAGE KO and wild type
samples. RAGE KO tissue specimens, which had consistently less
cartilage degradation, also showed a significantly lower percent-
age of chondrocytes, per defined area of articular cartilage, which
stained positive for HtrA-1 and Mmp-13 when compared to wild
type samples (p < 0.02 for HtrA-1 and p < 0.03 for Mmp-13,
see Figure 3). Furthermore, RAGE KO samples also consistently
demonstrated a higher number of chondrocytes in a defined area
Table 1 | Illustrated here is the presence or absence of HtrA-1 and
TGF-β1 in both wild type (WT) and RAGE KO samples as indicated by
immunohistochemistry.
Mouse HtrA-1 TGF-β1
RAGE KO 1 + −
RAGE KO 2 + −
RAGE KO 3 + −
RAGE KO 4 − +
RAGE KO 5 + −
WT 1 + −
WT 2 + −
WT 3* + +
WT 4 + −
WT 5 − +
WT 6 + −
*Indicates the only exception to the observed trend.
A significant trend was observed between the presence of HtrA-1 and TGF-β1
in both the RAGE KO and wild type samples. With the exception of WT 3, all
samples demonstrated a trend where samples which stained positive for HtrA-1
consistently stained negative for TGF-β1, while samples which stained negative
for HtrA-1 consistently stained positive for TGF-β1. The statistical significance
of this pattern was tested using a Chi-Squared test and was found to be highly
significant (p < 0.01).
FIGURE 2 | Representative images showing the results of the
immunohistochemical and histological stainings performed to
analyze the presence of OA biomarkers and cartilage
degradation. All tissue samples were harvested 28 days after the
DMM surgery. The images selected are representative of the
trends observed within wild type (A–E) (n = 5) and RAGE KO (F–J)
(n = 6) samples. The wild type and RAGE KO samples
demonstrated similar staining patterns in all biomarkers except
TGF-β1 where the RAGE KO samples demonstrated fewer samples
which stained positive. The difference was not statistically significant
when tested with a Chi-Squared test (p < 0.35). The scale bar,
valid for every image, is 50μm.
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of articular cartilage (mean = 60.8) when compared to wild type
samples (mean = 35, p < 0.02, see Figure 4).
IMMUNOHISTOCHEMICAL STAINING CORRELATED WITH SEVERITY OF
CARTILAGE DEGRADATION
When all mice samples from the 28 days post-surgery group
(RAGE KO and wild type samples; surgery and sham con-
trol samples, n = 24) were combined and sorted by modi-
fied Mankin score, significant differences were observed in the
presence of key OA biomarkers. Specifically, the presence of
Ddr-2 and HtrA-1 was observed in every specimen categorized
as late OA (Mankin scores >4, n = 8) in both the RAGE KO
and wild type samples. In contrast, samples characterized as
early OA (modified Mankin Scores of 1.5–3, n = 6), showed
a lower frequency of positive staining for HtrA-1 (p < 0.05,
see Figure 5). Positive staining for Mmp-13 was also consis-
tently observed in mice specimen of both samples categorized as
late OA.
FIGURE 3 | To resolve the similar immunohistochemical staining
patterns observed between RAGE KO and wild type samples despite
the protective effect seen in RAGE KO joints, the percentage of cells
staining positive for the given biomarkers was calculated at 400×
magnification in a defined 200 × 900 pixel area of articular cartilage
immediately distal to the tibial plateau. While both RAGE KO (n = 5)
and wild type (n = 6) samples stained positive for Mmp-13 and HtrA-1,
the wild type mice had a significantly higher percentage of cells which
stained positive for both Mmp-13 and Htr-A1 (∗p < 0.03 and p < 0.02
respectively).
FIGURE 4 | RAGE KO samples (n = 5), when compared to wild type samples (n = 6), demonstrated a significantly higher number of total
chondrocytes counted in a defined 200 × 900 pixel area of articular cartilage immediately distal to the tibial plateau at 400× magnification (∗p<0.02).
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FIGURE 5 | Mice (n = 24) were sorted independent of mouse
type (wild type vs. RAGE KO) and procedure (control vs. surgery)
based on the severity of cartilage degradation as indicated
by the modified Mankin score. The frequency of positive
immunohistochemistry staining for HtrA-1 and TGF-β1 for early OA
(Modified Mankin score of 1.5–3, n = 6) and late OA (Modified Mankin
score >4, n = 5) samples are shown here. The trend in frequency of
positive staining was compared using a Chi-Squared test. Positive TGF-β1
was observed at a high frequency in early OA samples, but at a
significantly lower frequency in late OA samples (∗∗p < 0.01). Conversely,
the frequency of HtrA-1 was significantly higher in late OA samples than
in early OA samples (∗p < 0.05).
When the RAGE KO and wild type samples were sorted by
modified Mankin score, a difference (p < 0.01) was also observed
for the presence of TGF-β1. In samples with minimal cartilage
degradation (modified Mankin scores <1.5), TGF-β1 was absent
in almost all samples (data not shown). At levels of cartilage
degradation characterized as early OA, all samples stained positive
for TGF-β1 (Figure 5). Finally, samples with cartilage degrada-
tion characterized as late OA, exhibited less staining for TGF-β1
(p < 0.01).
DISCUSSION
Effective treatment of OA is dependent on identifying the key
biomarkers and signaling mechanisms involved in its pathogen-
esis. Generally, previous research has described OA as a process
of mechanical degradation. More recently, it has suggested that
inflammatory processes may be key players in the early onset of
the disease (Berenbaum et al., 2013; Chockalingam et al., 2013;
Berenbaum, 2013). In the present study, we have demonstrated
clear involvement of RAGE and TGF-β1 in the pathogenesis and
progression of OA.
Management strategies of articular cartilage injuries or defects
in children and young adults are controversial and problem-
atic (Micheli et al., 2006; Macmull et al., 2011; Schmal et al.,
2013). Of consideration is determining the relative age of carti-
lage based upon chondrocyte-specific markers. HtrA1 has previ-
ously been shown to be important in regulating OA in humans
(Hadfield et al., 2008; Tiaden et al., 2012). Our study utilized
mice that were 4 weeks of age at initiation of surgery. Even at
this early age we demonstrate that OA progression followed a
similar metabolic pathway compared to what we have previously
reported in older mice (Holt et al., 2012). This lends support to
the idea that regardless of age or etiology, OA proceeds in a similar
manner.
Our results indicate that the absence of RAGE in mice does
provide a protective effect against the development of advanced
OA. These results and previous work (Zreiqat et al., 2010) contra-
dict the results of a study in which OA was induced by an ACL
destabilization process (Cecil et al., 2009). We believe this dis-
crepancy is caused by the severity of the ACL procedure and the
consequent morphological joint changes that occur.
While our results demonstrate that RAGE is a key biomarker
in the onset of OA, it is important to note that RAGE KO mice
still experienced moderate levels of cartilage degradation follow-
ing the DMM procedure. These results suggest that other sec-
ondary inflammatory signaling pathways closely associated with
the RAGE pathway, such as those initiated by Toll-like Receptors,
may also be activated following the surgical procedure (Bierhaus
et al., 2005; Bianchi, 2007).
Even though the histological analysis of the RAGE KO mice
showed less severe cartilage degradation as indicated by the
modified Mankin score, RAGE KO samples still showed a high
frequency of staining for OA biomarkers (HtrA-1, Ddr-2, and
MMP-13). It is important to recognize that IHC is not a quantita-
tive analysis. A quantitative assessment of immunohistochemical
staining demonstrated a lower percentage of RAGE KO chon-
drocytes staining positive for these biomarkers as compared to
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wild type samples (Figure 3). Additionally, we observed a higher
number of chondrocytes per given area in the articular cartilage.
The combination of these factors suggest that RAGE KO mice
have lower concentrations of the key OA biomarkers that medi-
ate the progression and onset of the disease (HtrA-1, Ddr-2, and
MMP-13) and that the tissue is healthier. Future research will be
focused on evaluating why RAGE KO mice are able to sustain
higher number of chondrocytes in the presence of mechanical
stress. Our current hypothesis is that RAGE KO mice are experi-
encing less apoptosis and consequently less cartilage degradation
leading to OA.
Our results on TGF-β1 and HtrA-1 suggest a relationship
between these two biomarkers. Transforming growth factor β1
(TGF-β1) has recently been implicated as a biomarker of OA
because of its role in the regulation of HtrA-1 in articular car-
tilage (Li et al., 2012). TGF-β1 primarily functions in the SMAD
signaling pathway and is considered a multifunctional cytokine
involved in many cellular processes including cell growth, prolif-
eration, differentiation, apoptosis, and the elaboration of extra-
cellular matrix. TGF-β1 has been implicated in cartilage repair
(van Beuningen et al., 2000). While the exact interaction between
RAGE and TGF-β1 is still unclear, it has been suggested that
cross talk occurs between similar to mothers against decapenta-
plegic (SMAD) and RAGE-mediated p38 MAPK signaling path-
ways required for TGF-β1-induced apoptosis in epithelial cells
(Dziembowska et al., 2007).
As reported in this present work, HtrA-1 positive staining
was only observed in tissues which stained negative for TGF-β1.
Furthermore, tissues with moderate cartilage degradation, early
OA, consistently stained positive for TGF-β1, while it was essen-
tially non-existent in specimen with late OA in which HtrA-1 was
present. These observations are consistent with previous work
demonstrating that HtrA-1 binds to and inhibits a broad range
of TGF-β1 family proteins (Oka et al., 2004). The present work
suggests that when HtrA-1 is expressed as OA progresses, TGF-β1
is inhibited. This could have significant implications in this dis-
ease. It is possible that in addition to degrading components of
the ECM, HtrA-1 may also inhibit the control of the inflamma-
tory response generated early in OA, serving to exacerbate the
progression of the disease.
The combination of our findings and those reported by others
(Oka et al., 2004) support the hypothesis that TGF-β1 is present
during the early onset of OA, induces the expression of HtrA-1,
and is then down-regulated, or potentially inhibited by HtrA-1.
Accordingly, if TGF-β1 is responsible for inducing the expres-
sion of HtrA-1 at early stages of OA, it may serve as a valuable
pharmaceutical target for future OA treatments. We are currently
examining that scenario.
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